APA (7th ed.) Citation

FSM, M., O, F., F, M., ZW, M., J, K., J, K., . . . M, S. (2024). Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study. Clinical genitourinary cancer, 22(2), 305. https://doi.org/10.1016/j.clgc.2023.11.013

Chicago Style (17th ed.) Citation

FSM, Monteiro, et al. "Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study." Clinical Genitourinary Cancer 22, no. 2 (2024): 305. https://doi.org/10.1016/j.clgc.2023.11.013.

MLA (9th ed.) Citation

FSM, Monteiro, et al. "Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study." Clinical Genitourinary Cancer, vol. 22, no. 2, 2024, p. 305, https://doi.org/10.1016/j.clgc.2023.11.013.